Approval · Notice of Compliance 22181 · 2019
TRANDOLAPRIL: Notice of Compliance 22181
Issued May 22, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22181
- Date
- May 22, 2019
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- MAVIK (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRANDOLAPRIL | 02488671 | Approved |
| TRANDOLAPRIL | 02488698 | Marketed |
| TRANDOLAPRIL | 02488701 | Marketed |
| TRANDOLAPRIL | 02488728 | Marketed |
Medicinal ingredients
- TRANDOLAPRIL 0.5 MG per CAP
- TRANDOLAPRIL 1 MG per CAP
- TRANDOLAPRIL 2 MG per CAP
- TRANDOLAPRIL 4 MG per CAP